Raloxifene Hydrochloride Tablet, Coated
Product Images NDC 71209-082

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Raloxifene Hydrochloride (NDC 71209-082). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cadila Pharmaceuticals Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Cont-label-60mg-100-tab.jpg (Cont Label 60mg 100 Tab)

Label for Raloxifene Hydrochloride Tablets, USP 60 mg, coated oral tablets. The label shows the product name, strength, and dosage form with a quantity of 100 tablets. It includes storage instructions, manufacturer's name Cadila Pharmaceuticals Ltd., and directions for pharmacists to dispense the Medication Guide. There is a barcode and a red text area noted for serialization data matrix code and batch coding.*

FDA Label Image

Cont Label 60mg 1000 Tab

Label for Raloxifene Hydrochloride Tablets, USP 60 mg, film-coated oral tablets. The label shows a carton design including the NDC 71209-082-11, directions for storage, medication guide dispensing instructions, and that the package contains 1000 tablets. The product is manufactured by Cadila Pharmaceuticals Limited in Gujarat, India. A barcode and a marked unvarnished area for serialization are also visible.*

FDA Label Image

Cont-label-60mg-2000-tab.jpg (Cont Label 60mg 2000 Tab)

Label for Raloxifene Hydrochloride Tablets, USP 60 mg, coated tablets, oral use. The label indicates 2000 tablets per container and is manufactured by Cadila Pharmaceuticals Limited, Ahmedabad, India. It includes storage instructions, a barcode, and a note to dispense an accompanying Medication Guide. The label also mentions the NDC number 71209-082-13 and a space for a serialized datamatrix code and batch coding.*

FDA Label Image

Cont-label-60mg-30-tab.jpg (Cont Label 60mg 30 Tab)

The image shows a label for Raloxifene Hydrochloride Tablets, USP, 60 mg coated tablets in a 30-tablet package. The label includes storage instructions, manufacturer information (Cadila Pharmaceuticals Limited, Gujarat State, India), and instructions to dispense the accompanying Medication Guide. It also features barcode and NDC number 71209-082-01. The product is marked Rx only.*

FDA Label Image

Raloxifene-spl-figure-1 (Raloxifene Spl Figure 1)

Two line graphs showing total hip mean percentage change from baseline over 24 months comparing placebo, Raloxifene Hydrochloride, and conjugated estrogens. The top graph compares placebo and Raloxifene Hydrochloride, while the bottom graph adds conjugated estrogens data for hysterectomized women. Both graphs plot percentage change against months after randomization, with annotations noting intent-to-treat analysis and last observation carried forward.*

FDA Label Image

Raloxifene-spl-strc.jpg (Raloxifene Spl Strc)

Chemical structure of Raloxifene hydrochloride, illustrating its molecular framework with characteristic rings and functional groups, including hydroxyl and chloride components.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.